Search
for
Sort by
Research 421–450 of 977
- Lessons From Epcot and Orlando 2014
- Dermatoses of Pregnancy
- A report on the Italian Hair Restoration Society's first surgical assistants meeting in Rome, Italy
- Hair Loss in Women: Common Causes, Diagnosis, and Management
- Laser facial hair removal protocol and key consultation considerations
- Zdravstvena njega bolesnika oboljelih od hipertireoze
- Primary care use of testosterone therapy to benefit women experiencing distress related to decreased sexual desire after surgical menopause
- Anxiety and depression disorders on health workers in COVID and non-COVID wards of Sanglah Hospital
- O PROCESSO DE ENFERMAGEM NO TRANSPLANTE CAPILAR: O IMPACTO DOS CUIDADOS PERIOPERATÓRIOS
- Profiling UK injectable aesthetic practitioners: A national cohort analysis
- Voluntary registers no longer have gravitas
- Conventional treatments in systemic lupus erythematosus
- Kemoterapinin En Görünen Yönü: Alopesi: Önlemek Mümkün Mü?
- Getting ahead of tinea capitis
- Update: The Pathogenesis and Treatment of PCOS
- Secondary amenorrhea
- Male, Female, Other: Transgender and the Impact in Primary Care
- Coping in Women With Polycystic Ovary Syndrome: Implications for Practitioners
- Zinc Deficiency in Suckling Mice Deprived of Colostrum
- Managing Polycystic Ovary Syndrome: A Cognitive Behavioral Strategy
- Cosmetic and Medical Electrolysis and Temporary Hair Removal
- Issue Information
- Cataracts and strabismus associated with hand rearing using artificial milk formulas in Bengal tiger (<i>Panthera tigris spp tigris</i>) cubs
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Arsenic Trioxide as Effective Therapy for Relapsed Acute Promyelocytic Leukemia
- Prevention and treatment of adverse effects related to chemotherapy for recurrent ovarian cancer
- The use of scalp cooling for chemotherapy-induced hair loss
- Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia
- Purpose-limited pharmaceutical product claims under the revised European Patent Convention: A camouflaged attack on generic substitution?